Interestingly, our pSer258-ATG13 ELISA study demonstrated a significant downregulation of pSer258-ATG13 from the BSL to the T1, T2, and T3 stages in N=40 ME/CFS patients. Here, ATG13 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.